Clinical outcomes of patients with hepatic insufficiency undergoing transcatheter aortic valve implantation: a systematic review and meta-analysis

Table 2 Patients baseline characteristics in the second analysis

Study	Patient number	Age	Male	Country
Alqahtani 2017
TAVR	134	71 ± 11	62.7%
SAVR	134	71 ± 10	59.0%	America
P	–	0.784	0.641
Dhoble 2017
TAVR	55	67.2	65.5%	America
SAVR	55	67.0	65.5%
P	–	0.893	1.00
Greason 2013
TAVR	6	NR	83.0%	America
SAVR	12	NR	83.0%
P	–	–	0.73
Khan 2020
TAVR	298	67.4 ± 8.6	71.6%	America
SAVR	901	65.7 ± 9.3	71.6%
P	–	< 0.01	0.98
Peeraphatdit 2020
TAVR	55	75.4 ± 9.4	70.9%	America
SAVR	50	68.4 ± 8.7	64.0%
P	–	0.0002	0.45
Seppelt 2020
TAVR	43	75.2	62.8%	Germany
SAVR	42	71.6	47.6%
P	–	NR	NR
Thakkar 2015
TAVR	36	73.36 ± 1.69	77.8%	America
SAVR	93	66.08 ± 0.89	67.7%
P	–	< 0.0001	0.3

NR not reported, TAVI transcatheter aortic valve implantation, SAVR surgical aortic valve replacement

ISSN: 1471-2261